EUVIMEDEUVIMED entdecken
Crossref

High-mobility group box-1 peptide ameliorates bronchopulmonary dysplasia by suppressing inflammation and fibrosis in a mouse model

Takeya Hara, Takashi Shimbo, Tatsuo Masuda, Tomomi Kitayama, Makoto Fujii, Morifumi Hanawa, Kazuha Yokota, Masayuki Endo, Takuji Tomimatsu, Tadashi Kimura, Katsuto Tamai

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.06.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Takeya Hara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Lung Injury, HMGB1 Protein, Hyperoxia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaLung InjuryHMGB1 ProteinHyperoxiaAnimalsHumansMiceInfant, NewbornAnimals, NewbornLungCytokinesInflammationDisease Models, AnimalFibrosis

Stichwörter der Autor:innen

Bronchopulmonary dysplasiaChronic lung disorderHMGB1Mesenchymal stem cellPeptideSingle-cell RNA sequencing

Substanzen

HMGB1 ProteinCytokines

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
  • Department of Stem Cell Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan; StemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Suita, Osaka, Japan.
  • StemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Suita, Osaka, Japan.
  • Department of Stem Cell Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan; StemRIM Inc., Ibaraki, Osaka, Japan.
  • StemRIM Institute of Regeneration-Inducing Medicine, Osaka University, Suita, Osaka, Japan; Department of Children's and Women's Health, Division of Health Science, Graduate School of Medicine, Osaka University, Suita,…
  • StemRIM Inc., Ibaraki, Osaka, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Hara, T., Shimbo, T., Masuda, T., Kitayama, T., Fujii, M., Hanawa, M., Yokota, K., Endo, M., Tomimatsu, T., Kimura, T., & Tamai, K. (2023). High-mobility group box-1 peptide ameliorates bronchopulmonary dysplasia by suppressing inflammation and fibrosis in a mouse model. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.06.032

Vancouver

Hara T, Shimbo T, Masuda T, Kitayama T, Fujii M, Hanawa M, et al. High-mobility group box-1 peptide ameliorates bronchopulmonary dysplasia by suppressing inflammation and fibrosis in a mouse model. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.06.032

BibTeX
@article{Hara2023,
  author = {Hara, Takeya and Shimbo, Takashi and Masuda, Tatsuo and Kitayama, Tomomi and Fujii, Makoto and Hanawa, Morifumi and Yokota, Kazuha and Endo, Masayuki and Tomimatsu, Takuji and Kimura, Tadashi and Tamai, Katsuto},
  title = {High-mobility group box-1 peptide ameliorates bronchopulmonary dysplasia by suppressing inflammation and fibrosis in a mouse model},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.06.032}
}
Kostenlos starten →